Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teligent Inc. | 725.000% | - | - | - | - | - | - |
| Dare Bioscience Inc. | 23.870% | 4.673% | -41.788% | -69.298% | -5.405% | -77.778% | - |
| Eledon Pharmaceuticals Inc. | 14.890% | 10.769% | 13.684% | 12.500% | 31.707% | -73.333% | -94.971% |
| Celldex Therapeutics | 5.680% | -3.825% | -8.808% | 7.317% | -2.762% | 39.572% | 562.900% |
| INSYS Therapeutics Inc | 5.000% | - | - | - | - | - | - |
| Acer Therapeutics Inc | 4.770% | - | - | - | - | - | - |
| TRACON Pharmaceuticals Inc. | 3.900% | - | - | - | - | - | - |
| Achieve Life Sciences Inc. | 3.890% | 0.819% | 2.133% | -42.914% | 14.628% | -52.637% | - |
| Protara Therapeutics Inc. | 2.820% | -5.517% | -27.128% | -5.517% | 65.060% | -89.388% | - |
| Evoke Pharma Inc. | 2.460% | 3.483% | -24.364% | -75.673% | -55.979% | -97.374% | -94.512% |
| Inotiv Inc. | 2.270% | -10.891% | -61.702% | -23.077% | 9.756% | - | - |
| aTyr Pharma Inc | 2.100% | -2.667% | -20.219% | -17.045% | 13.178% | -56.287% | -82.264% |
| Moleculin Biotech Inc | 1.530% | - | - | - | - | - | - |
| EyeGate Pharmaceuticals Inc | 1.310% | - | - | - | - | - | - |
| Vaxart Inc. | 0.520% | 2.123% | -43.898% | -8.517% | 30.625% | -92.490% | - |
| Riot Blockchain Inc. | 0.340% | -14.687% | -17.324% | -12.721% | -41.353% | -72.762% | - |
| SELLAS Life Sciences Group Inc | -0.170% | -19.247% | 24.249% | -12.006% | 18.769% | -82.307% | -99.685% |
| Cidara Therapeutics Inc | -0.620% | - | - | - | - | - | - |
| PDS Biotechnology Corp. | -0.820% | 12.126% | -16.160% | -43.146% | -31.726% | - | - |
| Qualigen Therapeutics Inc. | -2.110% | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -2.500% | - | - | - | - | - | - |
| Heat Biologics Inc. | -3.850% | 32.450% | 30.719% | -69.925% | -54.955% | -96.503% | - |
| vTv Therapeutics Inc | -6.980% | - | - | - | - | - | - |
| Aptevo Therapeutics Inc. | -10.290% | - | - | - | - | - | - |
| Tetraphase Pharmaceuticals | -10.670% | - | - | - | - | - | - |